|
|
|
|
|
|
|
M T W Thu F |
|
15 October, 2026 |
|
|
sponsored by
|
|
|
|
Delegate the Groundwork. Free Your Schedule to Advance the Science.
|
| Are you losing days chasing records across systems and assembling evidence before an investigation can begin? Katalyze AI delegates the groundwork to agents that gather the evidence and draft reports for you, with every finding connected back to its source. You review the results, challenge them in plain language, and decide what happens next. Built for GxP environments, Katalyze offers solutions for Yield Optimization, Deviation Investigation, Tech Transfer, and Raw Material Characterization. |
|
|
|
|
|
|
|
|
|
|
|
|
|
I'm headed home from San Francisco, where I got a good pulse check on where health AI is going. Are you interested in topics like that? I'll be in NYC on Nov. 5 hosting our second annual Health Tech Happy Hour. Get your tickets here. |
|
|
|
Lydia Ramsey Pflanzer |
Deputy Editor, Endpoints News
|
|
|
|
|
|
|
by Anna Brown
|
The state of Virginia is emerging as an early winner as President Donald Trump prods drugmakers to increase their manufacturing investments in the US, securing... | |
|
|
|
|
|
|
by Max Bayer
|
The CDC briefly published a webpage that maintained unequivocal support for Covid-19 vaccines in people preparing to have a baby, but it now redirects elsewhere... | |
|
|
|
|
|
|
by Kyle LaHucik
|
Nvidia-backed Iambic Therapeutics rose on its first day of trading after pricing its $150 million initial public offering Wednesday night. The cancer-focused biotech's stock
IAM... | |
|
|
|
|
|
|
|
|
by Ayisha Sharma
|
Vanda Pharmaceuticals said Wednesday it is putting its social anxiety disorder program on hold following a late-stage trial failure. The biotech’s drug, called VQW-765, missed... | |
|
|
|
 |
|
|
|
by ENDPOINTS |
Plus news about ImmunityBio, Modus Therapeutics and Hyperway Pharmaceutical. AstraZeneca strikes AI drug discovery deal with insitro: The pharma giant will paythe California-based company... | |
|
|
|
|
|
